The purpose was to develop and establish an original high-performance
liquid chromatographic (HPLC) arrangement for the discrimination and e
valuation of the components of a drug. The bulk ibuprofen drug powder
was assayed as a model compound. The HPLC stationary phase was that of
the P-cyclodextrin bond silica gel; the phosphate buffered drug solut
ion was applied in the function of the HPLC mobile phase. The drug sam
ples investigated were prepared by a procedure identical to that of th
e eluent. On injecting the assayed sample into the eluent stream the c
ontent of each drug component was estimated either from the positive o
r negative HPLC detector response. Nil output signal indicates that in
the sample analyzed the investigated component level is identical wit
h the concentration of that component run in the HPLC mobile phase use
d.